Clinical trial
Combination Chemotherapy With or Without Thalidomide in Treating Patients With…
NCT00028886 · Commissie Voor Klinisch Toegepast Onderzoek, Other · Unknown status
Key facts
| NCT number | NCT00028886 |
|---|---|
| Title | Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma |
| Official title | A Randomized Phase III Study On The Effect Of Thalidomide Combined With Adriamycin, Dexamethasone (AD) And High Dose Melphalan In Patients With Multiple Myeloma |
| Lead sponsor | Commissie Voor Klinisch Toegepast Onderzoek, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, recombinant interferon alfa, cyclophosphamide, dexamethasone, doxorubicin hydrochloride, melphalan, thalidomide, vincristine sulfate, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Enrollment | 450 |
| Start date | Mar 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Belgium, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: